New insights into disease progression for the CFTR modulator-treated cystic fibrosis patient

Susanna A. McColley; Jane Davies; Felix Ratjen; Manu Jain

doi:10.1016/j.jcf.2015.12.014

New insights into disease progression for the CFTR modulator-treated cystic fibrosis patient

Susanna A. McColley, Jane Davies, Felix Ratjen, Manu Jain

Research output: Contribution to journal › Article › peer-review

Abstract

This educational activity is adapted from a live satellite symposium held during the 29th Annual North American Cystic Fibrosis Conference in Phoenix, Arizona (online access: http://www.elseviercme.com/cysticfibrosis/598e). This educational symposium will update clinicians on the changes in disease progression that are now seen in CFTR modulator-treated patients. With the recent scientific advancements and the principles of precision medicine, disease progression and quality of life are drastically improving for patients with cystic fibrosis. Current clinical trial data shows new and emerging therapeutic options that are beneficial to specific gene mutations. Expert faculty will present comprehensive case studies and conduct interactive panel discussions to enhance your knowledge in the advanced science of cystic fibrosis and patient management strategies.

Original language	English (US)
Pages (from-to)	e21
Journal	Journal of Cystic Fibrosis
Volume	15
Issue number	2
DOIs	https://doi.org/10.1016/j.jcf.2015.12.014
State	Published - Mar 1 2016

ASJC Scopus subject areas

Pediatrics, Perinatology, and Child Health
Pulmonary and Respiratory Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.jcf.2015.12.014

Cite this

@article{c057193e5e064c249792b9e996f4d536,

title = "New insights into disease progression for the CFTR modulator-treated cystic fibrosis patient",

abstract = "This educational activity is adapted from a live satellite symposium held during the 29th Annual North American Cystic Fibrosis Conference in Phoenix, Arizona (online access: http://www.elseviercme.com/cysticfibrosis/598e). This educational symposium will update clinicians on the changes in disease progression that are now seen in CFTR modulator-treated patients. With the recent scientific advancements and the principles of precision medicine, disease progression and quality of life are drastically improving for patients with cystic fibrosis. Current clinical trial data shows new and emerging therapeutic options that are beneficial to specific gene mutations. Expert faculty will present comprehensive case studies and conduct interactive panel discussions to enhance your knowledge in the advanced science of cystic fibrosis and patient management strategies.",

author = "McColley, {Susanna A.} and Jane Davies and Felix Ratjen and Manu Jain",

note = "Publisher Copyright: {\textcopyright} 2015 European Cystic Fibrosis Society.",

year = "2016",

month = mar,

day = "1",

doi = "10.1016/j.jcf.2015.12.014",

language = "English (US)",

volume = "15",

pages = "e21",

journal = "Journal of Cystic Fibrosis",

issn = "1569-1993",

publisher = "Elsevier B.V.",

number = "2",

}

TY - JOUR

T1 - New insights into disease progression for the CFTR modulator-treated cystic fibrosis patient

AU - McColley, Susanna A.

AU - Davies, Jane

AU - Ratjen, Felix

AU - Jain, Manu

PY - 2016/3/1

Y1 - 2016/3/1

N2 - This educational activity is adapted from a live satellite symposium held during the 29th Annual North American Cystic Fibrosis Conference in Phoenix, Arizona (online access: http://www.elseviercme.com/cysticfibrosis/598e). This educational symposium will update clinicians on the changes in disease progression that are now seen in CFTR modulator-treated patients. With the recent scientific advancements and the principles of precision medicine, disease progression and quality of life are drastically improving for patients with cystic fibrosis. Current clinical trial data shows new and emerging therapeutic options that are beneficial to specific gene mutations. Expert faculty will present comprehensive case studies and conduct interactive panel discussions to enhance your knowledge in the advanced science of cystic fibrosis and patient management strategies.

AB - This educational activity is adapted from a live satellite symposium held during the 29th Annual North American Cystic Fibrosis Conference in Phoenix, Arizona (online access: http://www.elseviercme.com/cysticfibrosis/598e). This educational symposium will update clinicians on the changes in disease progression that are now seen in CFTR modulator-treated patients. With the recent scientific advancements and the principles of precision medicine, disease progression and quality of life are drastically improving for patients with cystic fibrosis. Current clinical trial data shows new and emerging therapeutic options that are beneficial to specific gene mutations. Expert faculty will present comprehensive case studies and conduct interactive panel discussions to enhance your knowledge in the advanced science of cystic fibrosis and patient management strategies.

UR - http://www.scopus.com/inward/record.url?scp=84960850277&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84960850277&partnerID=8YFLogxK

U2 - 10.1016/j.jcf.2015.12.014

DO - 10.1016/j.jcf.2015.12.014

M3 - Article

AN - SCOPUS:84960850277

SN - 1569-1993

VL - 15

SP - e21

JO - Journal of Cystic Fibrosis

JF - Journal of Cystic Fibrosis

IS - 2

ER -

New insights into disease progression for the CFTR modulator-treated cystic fibrosis patient

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this